Our systematic review discusses previous studies on the diagnostic use of salivary MPO levels in patients with systemic diseases, such as cardiovascular diseases, respiratory disorders, gastrointestinal diseases, haematological disorders, infectious and immunological disorders, autoimmunological disorders, and others. This evidence concerns the gene MPO and gastrointestinal disease.